0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Renal Function and Blood Pressure in Patients Receiving Long-Term, Low-Dose Cyclosporine Therapy for Idiopathic Autoimmune Uveitis

Gilbert Deray, MD; Mohamed Benhmida, MD; Phuc Le Hoang, MD; Philippe Maksud, MD; Brigitte Aupetit, MD; Alain Baumelou, MD; and Claude Jacobs
[+] Article and Author Information

Grant Support: In part by a grant from the Fondation de l'Avenir (90/21).

Requests for Reprints: Gilbert Deray, MD, Service de Néphrologie, Hôpital de la Pitié, 83 boulevard de l'Hôpital, 75013 Paris, France.

Current Author Addresses: Drs. Deray, Benhmida, Le Hoang, Maksud, Aupetit, Baumelou, and Jacobs: Hôpital de la Pitié, 83 boulevard de l'Hôpital, 75013 Paris, France.


© 1992 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1992;117(7):578-583. doi:10.7326/0003-4819-117-7-578
Text Size: A A A

Objective: To determine the renal side effects of long-term, low-dose cyclosporine therapy (initial dose, 5 mg/kg body weight per day) in patients with autoimmune idiopathic uveitis.

Design: Cohort study with at least 2 years of follow-up.

Setting: A teaching hospital in Paris, France (Hôpital Pitié-Salpétrière).

Patients: Sixteen patients with idiopathic autoimmune uveitis who were normotensive and had normal renal function before treatment. Cyclosporine was administered orally for at least 2 years at an initial dosage of 5 mg/kg body weight per day.

Results: After 2 years of treatment, the serum creatinine level increased by 35 ± 5 µmol/L (0.40 ± 0.06 mg/dL) (95% CI, 25 to 46 µmol/L, [73 ± 4 to 108 ± 4 µmol/L]). Creatinine clearance decreased significantly from 120 ± 5 mL/min to 75 ± 4 mL/min. Glomerular filtration rate decreased from 116 ± 8 mL/min to 75 ± 3 mL/min, and effective renal plasma flow decreased from 455 ± 24 mL/min to 338 ± 30 mL/min (P < 0.05). Cyclosporine induced a significant increase in serum uric acid, total cholesterol, and serum potassium levels. Blood pressure was normal in all patients before treatment; 81% (95% CI, 64% to 98%) of these patients developed hypertension after 24 months of treatment. Blood pressure was controlled with a single drug in all but two patients.

Conclusions: In patients with healthy native kidneys, long-term cyclosporine therapy, even at a low dose (5 mg/kg per day), is nephrotoxic and is associated with a high incidence of hypertension.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)